Knee OA Drug's Long-Term safety under watch in small study
NCT ID NCT05752032
First seen Mar 29, 2026 · Last updated May 25, 2026 · Updated 2 times
Summary
This study follows 16 people who previously received the experimental drug ICM-203 or a placebo for knee osteoarthritis. Researchers will track any delayed side effects and measure changes in knee pain and function over time. The goal is to understand the long-term safety and effectiveness of the treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS, KNEE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Barwon Health
Geelong, Victoria, 3220, Australia
-
Royal Adelaide Hospital
Adelaide, South Australia, 5000, Australia
Conditions
Explore the condition pages connected to this study.